Skip to main content
. 2017 Sep 27;12:2777–2785. doi: 10.2147/COPD.S146041

Table 1.

Demographic comparison and initial clinical situation of groups (n=60)

Variables COPD
(n=40)
Control
(n=20)
p-value
Male, n (%) 20 (50%) 13 (65%) 0.40
Age, years 66.95±5.87 65.95±4.55 0.50
BMI, kg/m2 28.65±5.06 27.71±5.20 0.50
Comorbidities, n (%) 25 (62.5%) 15 (37.5%) 0.28
Diabetes, n (%) 12 (30%) 6 (30%) 0.76
SAH, n (%) 22 (55%) 9 (45%) 0.64
CHF, n (%) 7 (17.5%) 5 (25%) 0.51
Alcohol consumption, n (%) 7 (17.5%) 4 (20%) 1.00
Retirees, n (%) 16 (40%) 12 (60%) 0.23
FEV1 % of the predicted 59.05±12.44 91.50±12.47 <0.001
FVC, % of the predicted 63.12±10.06 91.25±15.56 <0.001
FEF25%–75%, % of the predicted 46.67±10.49 85.95±17.11 <0.001
Cough, n (%) 12 (30%) 0 (0%) <0.001
Expectoration, n (%) 12 (30%) 0 (0%) <0.001
Wheezing, n (%) 21 (52.5%) 0 (0%) <0.001
Dyspnea, n (%) 33 (82.5%) 0 (0%) <0.001

Notes: Data are presented as mean ± standard deviation or absolute number (frequency). FEV1, FVC and FEF25%–75% are expressed as % of predicted.33

Abbreviations: n, absolute number; BMI, body mass index; SAH, systemic arterial hypertension; CHF, congestive heart failure; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; FEF25%–75% = forced expiratory flow at the moment between 25% and 75% of the curve, p-value of the t-test or chi-square test.